TITLE

Presenting Risk in Drug Advertising

AUTHOR(S)
Heisey, Colleen; Chernove, Arianna
PUB. DATE
September 2010
SOURCE
Contract Pharma;Sep2010, Vol. 12 Issue 7, p18
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on the publication of a proposed rule by the U.S. Food and Drug Administration (FDA) that is aimed for the amendment of radio and television direct-to-consumer (DTC) advertising regulations for prescription drugs. The amendment seeks to include standards by which FDA will identify if a television or radio advertisement contains major statement that meets neutral standard. FDA proposed the effectivity of the rule 90 days after its publication in the Federal register.
ACCESSION #
53384981

 

Related Articles

  • Govt delays ruling on self-regulation.  // Campaign;11/22/2002, Issue 47, p1 

    Reports on the setback to the Great Britain advertising industry regarding their hopes of a self-regulatory system for television and radio commercials. Lack of any reference to the system in the Communications bill passed by the government; Provisions of the bill.

  • New FDA TV drug rules promise ad boom. Wilke, Michael; Krol, Carol; Ross, Chuck // Advertising Age;8/11/1997, Vol. 68 Issue 32, p3 

    This article reports on an increase in new prescription drug television commercials after the issuance of more specific broadcast advertising guidelines by the U.S. Food and Drug Administration in August 1997. Drug commercials can now name the brand and the condition it treats. Such commercials...

  • Agenda watch.  // Advertising Age;7/14/1997, Vol. 68 Issue 28, p18 

    The article addresses the issue of the extent of the power of the United States Federal Communications Commission (FCC) and the Food and Drug Administration (FDA) in monitoring television advertisements for the liquor and pharmaceutical industries. The article also discusses the effect of FDA...

  • BROADCAST COMMERCIAL ACCEPTANCE.  // Marketing (00253650);Oct2014 Supplement Media Digest, p60 

    The article focuses on the Telecaster Committee of Canada (TVB) that was founded by private broadcasters group in 1973. Topics discussed include the organization's general rule in the radio and television (TV) commercials, the issuance of final clearance for TV commercial, infomercials, and...

  • Calls for ad-free children's TV. Cozens, Claire // Campaign;09/25/98, Issue 39, p18 

    Reports that the Swedish government is lobbying to have advertising restrictions placed on television programming for children, under age twelve across the European Union. Information on the two-pronged ban which protects these children from advertisements in Sweden; Reference to research which...

  • A critical look at prescription drug direct-to-consumer advertising.  // Formulary;Feb2007, Vol. 42 Issue 2, p125 

    The article discusses several issues surrounding the direct-to-consumer advertising (DTCA) of prescription drugs since its approval in 1997 by the U.S. Food and Drug Administration (FDA). There has been an increasing debate regarding the methods used by advertisers in influencing the consumers...

  • Evaluating the Welfare Effects of Drug Advertising. Bardford, W. David; Kleit, Andrew N. // Regulation;Spring2006, Vol. 29 Issue 1, p58 

    Discusses the health benefits of drug advertisements to consumers. Changes implemented by the U.S. Food and Drug Administration on the rules for the broadcast of direct-to-consumer advertising (DCA) of prescription drugs in August 1997; Effect of DCA on physicians and patients; Evaluative...

  • Give It To Me Straight! Comer, Ben // Pharmaceutical Executive;Dec2011, Vol. 31 Issue 12, p67 

    The article reports on the significance of direct-to-consumer prescription drug advertisement in drug facts boxes in the U.S. in 2011. It mentions that the boxes are aimed in offering consumers and physicians simple analysis of clinical data, noting that it contributes to a more informed...

  • FDA to probe website DTC risk/benefit. M. A. // Medical Marketing & Media;Jun2011, Vol. 46 Issue 6, p25 

    The article reports on the plans of the U.S. Food and Drug Administration (FDA) to study online consumer advertising for prescription drugs in order to resolve the issue on how to achieve fair balance in online direct-to-consumer (DTC) promotion.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics